Common Problems and Mistakes in Method Validation in drug development process

Instructor: Dr. Wise Blackman
Product ID: 700267
Training Level: Intermediate to Advanced
  • Duration: 60 Min

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

This Method Validation training in drug development process will provide guidance in setting appropriate specifications, determining if the assay is validatable, and monitoring progress during the validation.


This web seminar will address frequently observed issues and problems with method validations.

Validated methods are required for Phase III of the drug development process. Setting appropriate specifications and criteria based on solid data from development and qualification will contribute to successful completion of method validations. Key issues may be overlooked or not anticipated when methods are developed, optimized, and qualified that can lead to assay failures during validation. Rushing to judgement can lead to unecessary delays and repeated work.

Areas Covered in the seminar:

  • Importance of defining the method and trending necessary information. Importance of setting appropriate specifications.
  • Designing appropriate assays
  • Establishing correct specifications
  • Identifying an appropriate reference standard
  • Building on the foundationof a good qualification
  • Creating effective templates for validation studies

Who Will Benefit:

This webinar will provide guidance in setting appropriate specifications, determining if the assay is validatable, and monitoring progress during the validation.

  • Laboratory personnel responsible for day-to-day functioning of laboratories
  • Laboratory managers monitoring critical systems and reportable results
  • Scientific staff involved in assay development, qualification, and/or validation

Instructor Profile:

Dr. Wise-Blackman, is currently Senior Manager, Cellular Technologies, at the Cardinal Health RTP-Bio site. Dr. Wise-Blackman leads a team that successfully develops, optimizes, validates, and performs cell-based assays for lot release and stability projects in a GxP environment She was the co-recipient of both the Customer Focus Award for 3rd Quarter FY2004 and the Presidents Award for FY2004. Her expertise is GMP bioassays to support release and stability testing of biotechnology products, GLP ELISA assay development and validation, Cell Based Screens, and Receptor Binding Assays. Dr. Wise-Blackman was previously employed at Dupont Pharmaceuticals for nine years, working in the cardiovascular pharmacology and high throughput screening departments. She received her Ph.D. in Pharmacology from the University of Virginia, Charlottesville, VA and her Bachelor of Science in Biology from the Massachusetts Institute of Technology, Cambridge, MA.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed